Test Price
2,800 AED✅ Home Collection Available
GNE Gene Nonaka Myopathy Genetic Test in UAE | 2800 AED | DHA Guidelines
Executive Summary & Core Metrics
99.9% diagnostic sensitivity via ISO-accredited next‑generation sequencing (NGS) at DNA Labs UAE – DHA Licensed Facility #1143. The test screens the entire GNE gene coding region for pathogenic variants linked to distal myopathy with rimmed vacuoles (Nonaka myopathy). Includes VIP mobile phlebotomy and temperature‑controlled cold‑chain home collection (daily 8 AM–11 PM), telephonic post‑test genetic counselling by a DHA‑licensed Consultant Medical Geneticist, and instant insurance verification via WhatsApp at +971 54 548 8731. Turnaround time: 3–4 weeks. Price: 2,800 AED.
Test Overview & Methodology
The GNE Gene Nonaka Myopathy NGS Test uses validated next‑generation sequencing chemistry on the Illumina platform to detect single‑nucleotide variants, small insertions/deletions, and exon‑level copy number variations in the GNE gene. Bioinformatics analysis aligns reads to GRCh38 and classifies variants per ACMG/AMP guidelines. This molecular approach is essential for confirming a clinical diagnosis of Nonaka myopathy, differentiating it from other distal myopathies, and providing accurate carrier risk assessment for family planning.
| Parameter | Our Test (NGS Platform) | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Precision | >99.9% analytical sensitivity & specificity across whole gene | ~97% single‑exon focus; misses deep intronic variants |
| Method | Next‑Generation Sequencing (LC‑MS/MS validated library prep) | Capillary electrophoresis – limited to pre‑defined hotspots |
| Turnaround | 3–4 weeks inclusive of bioinformatics verification | 6–8 weeks for full gene coverage by multiple reactions |
| UAE Compliance | DHA/MOHAP nomenclature, ISO 9001:2015, PDPL‑compliant report | Variable; often lacks local legal alignment |
Physician Insight & Safety Protocols
“As a DHA‑licensed Consultant Medical Geneticist, I emphasise that this test provides definitive molecular evidence for Nonaka myopathy. However, results must always be interpreted alongside clinical examination and electrodiagnostic studies. A negative result does not exclude all myopathies; comprehensive genetic counselling is integral to the process.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Medication Advisory
Do not discontinue any prescribed medication, particularly corticosteroids or immunosuppressants, without explicit instruction from your treating physician. Abrupt withdrawal can provoke severe myopathic or systemic reactions.
Exclusion & Emergency Criteria
Exclusion Criteria
- Active febrile illness (postpone collection for 72 hours afebrile)
- Non‑consenting minors without legal guardian (informed consent required per UAE PDPL)
- Inability to provide verifiable clinical history pedigree
- Severe anemia (Hb < 7 g/dL) with hemodynamic instability – require physician clearance
Emergency Red Flags
- Acute respiratory distress or bulbar weakness – proceed to ER immediately
- Rapidly progressive quadriparesis within days
- Severe dysphagia with choking
- Cardiac arrhythmia or new‑onset cardiomyopathy symptoms
Patient FAQ & Clinical Guidance
1. How accurate is the GNE gene NGS test for diagnosing Nonaka myopathy?
Direct Answer: The test achieves 99.9% diagnostic sensitivity for known GNE mutations, detecting single‑nucleotide variants, small indels, and exon‑level copy number changes through validated NGS chemistry.
2. Can I use my insurance to pay for this test in the UAE?
Direct Answer: Yes, we verify coverage from all major UAE insurers (including DHA‑approved Takaful and international plans) via a 5‑minute WhatsApp eligibility check before your home collection.
3. Is genetic counselling mandatory before the test?
Direct Answer: A pre‑genetic counselling session is mandatory to build a three‑generation pedigree, obtain informed consent, and explain possible outcomes, in compliance with UAE PDPL.
UAE Regulatory & Data Privacy Adherence
This genetic test is conducted in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data is processed and stored exclusively within UAE jurisdiction. Clinical safety and patient consent adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. DNA Labs UAE holds DHA Facility License No. 1143 and is ISO 9001:2015 certified.
Clinical & Logistical Metadata
| Test Name | GNE Gene Nonaka Myopathy NGS Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 weeks |
| Sample Type / Matrix | Peripheral whole blood (EDTA tube) – VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection available |
| Methodology Used | Next‑Generation Sequencing (NGS) on Illumina platform, bioinformatics analysis per ACMG/AMP guidelines |
| ICD-10-CM Code | G71.0 |
| LOINC Code | 21636-6 |
| DHA Facility License & Laboratory Address | DHA License 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians